The Journal of Clinical Endocrinology & Metabolism · 1992 · 102 citations · 17 references
MedicineEndocrinologyPediatricsBone MetabolismCalcium HomeostasisMineral MetabolismDisorders Of Phosphate MetabolismParathyroid DisordersParathyroid Gland PhysiologyParathyroid Hormone RegulationParathyroid SurgeryPhosphate HomeostasisHyperparathyroidism Medical ManagementParathyroid Cell FunctionParathyroid DysfunctionParathyroid Function AssessmentParathyroid Gland FunctionParathyroid PathologyPhosphate Replacement TherapyTertiary Hyperparathyroidism Treatment
We report the development of severe tertiary hyperparathyroidism in three girls treated for familial hypophosphatemic rickets and characterize parathyroid function in vivo and in vitro. All patients had been previously treated with relatively large doses of inorganic phosphorus (125 mm/day) and ergocalciferol or calcitriol for several years and had radiographic evidence of long-standing hyperparathyroidism. Even in the presence of extremely elevated PTH levels, oral phosphate lowered serum calcium levels in vivo and further stimulated PTH secretion. Profound multiglandular parathyroid hyperplasia was found in each patient at surgery. Examination of the secretory characteristics of the excised parathyroid tissue revealed that either relatively high calcium concentrations were generally needed to suppress PTH secretion or PTH secretion was not suppressible. Caution is recommended when relatively large doses of phosphate are used to treat familial hypophosphatemic rickets.
17
Voluntary Medical Care Insurance in the United States
JAMA · 1949 · 459 citations
RICKETS RESISTANT TO VITAMIN D THERAPY
Fuller Albright · Archives of Pediatrics and Adolescent Medicine · 1937 · 448 citations